CELL-BASED SYSTEMS FOR PRODUCING INFLUENZA VACCINES
    8.
    发明申请
    CELL-BASED SYSTEMS FOR PRODUCING INFLUENZA VACCINES 有权
    用于生产流感疫苗的基于细胞的系统

    公开(公告)号:US20100021499A1

    公开(公告)日:2010-01-28

    申请号:US12481402

    申请日:2009-06-09

    IPC分类号: A61K39/145 C12N7/04 C12N5/07

    摘要: The present invention relates to a cell-based method for producing influenza virus vaccines by enriching the population of surface-bound α2,6-sialic acid receptors on a cell surface, such as on a Chinese Hamster Ovary (CHO) cell surface. The host cell therefore presents numerous binding sites to which an influenza virus can bind via its hemagglutinin spike protein and infect the host cell. In contrast to wild-type CHO cells, the surface of the mutated CHO cells of the present invention contains an enriched population of α2,6-sialic acid receptors which makes the inventive CHO cells highly susceptible to viral infection, and therefore safe, effective, and highly efficient cells for rapidly producing influenza vaccines.

    摘要翻译: 本发明涉及通过富集细胞表面如中国仓鼠卵巢(CHO)细胞表面上的表面结合的α2,6-唾液酸受体的群体来生产流感病毒疫苗的基于细胞的方法。 因此,宿主细胞呈现许多结合位点,流感病毒可以通过其血凝素尖峰蛋白结合并感染宿主细胞。 与野生型CHO细胞相比,本发明的突变的CHO细胞的表面含有富含α2,6-唾液酸受体的群体,这使得本发明的CHO细胞对病毒感染高度敏感,因此安全,有效, 以及用于快速生产流感疫苗的高效细胞。